The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TLDR
The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.Abstract:
Flaws in the design, conduct, analysis, and reporting of randomised trials can cause the effect of an intervention to be underestimated or overestimated. The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurateread more
Citations
More filters
Journal ArticleDOI
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer,David Moher,Mike Clarke,Davina Ghersi,Alessandro Liberati,Mark Petticrew,Paul G. Shekelle,Lesley A. Stewart +7 more
TL;DR: The PRISMA-P checklist as mentioned in this paper provides 17 items considered to be essential and minimum components of a systematic review or meta-analysis protocol, as well as a model example from an existing published protocol.
Journal ArticleDOI
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne,Jelena Savović,Jelena Savović,Matthew J. Page,Roy G Elbers,Natalie S Blencowe,Isabelle Boutron,Isabelle Boutron,Isabelle Boutron,Christopher J Cates,Hung-Yuan Cheng,Mark Corbett,Sandra Eldridge,Jonathan Emberson,Miguel A. Hernán,Sally Hopewell,Asbjørn Hróbjartsson,Asbjørn Hróbjartsson,Daniela R Junqueira,Peter Jüni,Jamie J Kirkham,Toby J Lasserson,Tianjing Li,Alexandra McAleenan,Barnaby C Reeves,Sasha Shepperd,Ian Shrier,Lesley A. Stewart,Kate Tilling,Ian R. White,Penny Whiting,Penny Whiting,Julian P T Higgins,Julian P T Higgins +33 more
TL;DR: The Cochrane risk-of-bias tool has been updated to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Journal ArticleDOI
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny Whiting,Anne W S Rutjes,Marie Westwood,Susan Mallett,Jonathan J Deeks,Johannes B. Reitsma,Mariska M.G. Leeflang,Jonathan A C Sterne,Patrick M.M. Bossuyt +8 more
TL;DR: The QUADAS-2 tool will allow for more transparent rating of bias and applicability of primary diagnostic accuracy studies.
Journal ArticleDOI
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan A C Sterne,Miguel A. Hernán,Barnaby C Reeves,Jelena Savović,Jelena Savović,Nancy D. Berkman,Meera Viswanathan,David Henry,Douglas G. Altman,Mohammed T. Ansari,Isabelle Boutron,James R. Carpenter,An-Wen Chan,Rachel Churchill,Jonathan J Deeks,Asbjørn Hróbjartsson,Jamie J Kirkham,Peter Jüni,Yoon K. Loke,Theresa D Pigott,Craig R Ramsay,Deborah L. Regidor,Hannah R. Rothstein,Lakhbir Sandhu,Pasqualina Santaguida,Holger J. Schünemann,Beverly Shea,Ian Shrier,Peter Tugwell,Lucy Turner,Jeffrey C. Valentine,Hugh Waddington,Elizabeth Waters,George A. Wells,Penny Whiting,Julian P T Higgins +35 more
TL;DR: Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
Journal ArticleDOI
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
TL;DR: This meta-analysis of RCT and observational studies found that the use of probiotics was beneficial for the prevention of severe NEC, late-onset sepsis, and all-cause mortality in VLBW infants.
References
More filters
Journal ArticleDOI
The landscape and lexicon of blinding in randomized trials.
TL;DR: The landscape and lexicon of blinding in randomized trials in the hope of untangling some of that terminology, which is widely recognized as reducing differential assessment of outcomes of interest.
Book ChapterDOI
Presenting Results and ‘Summary of Findings’ Tables
Holger J. Schünemann,Andrew D Oxman,Julian P T Higgins,Gunn Elisabeth Vist,Paul Glasziou,Gordon H. Guyatt +5 more
Journal ArticleDOI
A review of critical appraisal tools show they lack rigor: Alternative tool structure is proposed
TL;DR: The basic structure for a comprehensive CAT is suggested that requires further study to verify its overall usefulness and users of CATs should be careful about which CAT they use and how they use it.
Journal ArticleDOI
Turning a Blind Eye: The Success of Blinding Reported in a Random Sample of Randomised, Placebo Controlled Trials
TL;DR: The current lack of reporting on the success of blinding provides little evidence that success of blindness is maintained in placebo controlled trials, according to a random sample of 200 randomised clinical trials.
Journal ArticleDOI
Randomized trials published in some Chinese journals: how many are randomized?
TL;DR: Most reports of randomized controlled Trials published in some Chinese journals were not real randomized controlled trials owing to a lack of adequate understanding on the part of the authors of rigorous clinical trial design and a good practice guide for peer review needs to be developed.